McCann, L. J., Livermore, P., Wilkinson, M. G. L. & Wedderburn, L. R. Juvenile dermatomyositis. Where are we now? Clin. Exp. Rheumatol. 40, 394–403 (2022).
Mondal, S., Barman, P. & Vignesh, P. Cardiovascular abnormalities in juvenile dermatomyositis: a scoping review for the clinical rheumatologists. Front. Med. 9, 827539 (2022).
Mavrogeni, S. et al. Myocarditis during acute inflammatory myopathies: evaluation using clinical criteria and cardiac magnetic resonance imaging. Int. J. Cardiol. 164, e3–e4 (2013).
Mavrogeni, S., Douskou, M. & Manoussakis, M. N. Contrast-enhanced CMR imaging reveals myocardial involvement in idiopathic inflammatory myopathy without cardiac manifestations. JACC Cardiovasc. Imaging 4, 1324–1325 (2011).
Bohan, A. & Peter, J. B. Polymyositis and dermatomyositis (first of two parts). N. Engl. J. Med. 292, 344–347 (1975).
Article CAS PubMed Google Scholar
Bohan, A. & Peter, J. B. Polymyositis and dermatomyositis (second of two parts). N. Engl. J. Med. 292, 403–407 (1975).
Article CAS PubMed Google Scholar
Lundberg, I. E. et al. 2017 European League Against Rheumatism/American College of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol. 69, 2271–2282 (2017).
Article PubMed PubMed Central Google Scholar
Huber, A. M. et al. Validation and clinical significance of the childhood myositis assessment scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum. 50, 1595–1603 (2004).
Cerqueira, M. D. et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105, 539–542 (2002).
Page, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, 71 (2021).
Pereira, R. M., Lerner, S., Maeda, W. T., Goldenstein-Schainberg, C. & Cossermelli, W. Pericardial tamponade in juvenile dermatomyositis. Clin. Cardiol. 15, 301–303 (1992).
Article CAS PubMed Google Scholar
Jimenez, C., Rowe, P. C. & Keene, D. Cardiac and central nervous system vasculitis in a child with dermatomyositis. J. Child Neurol. 9, 297–300 (1994).
Article CAS PubMed Google Scholar
Shehata, R. et al. Juvenile dermatomyositis: clinical profile and disease course in 25 patients. Clin. Exp. Rheumatol. 17, 115–118 (1999).
Hicks, J. E., Drinkard, B., Summers, R. M. & Rider, L. G. Decreased aerobic capacity in children with juvenile dermatomyositis. Arthritis Rheum. 47, 118–123 (2002).
Takken, T., Spermon, N., Helders, P. J., Prakken, A. B. & Van Der Net, J. Aerobic exercise capacity in patients with juvenile dermatomyositis. J. Rheumatol. 30, 1075–1080 (2003).
Karaca, N. E., Aksu, G., Yeniay, B. S. & Kutukculer, N. Juvenile dermatomyositis with a rare and remarkable complication: sinus bradycardia. Rheumatol. Int. 27, 179–182 (2006).
Sallum, A. M. et al. Risk factors associated with calcinosis of juvenile dermatomyositis. J. Pediatr. 84, 68–74 (2008).
Sakurai, N., Nagai, K., Tsutsumi, H. & Ichimiya, S. Anti-CADM-140 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and cardiac involvement. J. Rheumatol. 38, 963–964 (2011).
Schwartz, T., Sanner, H., Husebye, T., Flato, B. & Sjaastad, I. Cardiac dysfunction in juvenile dermatomyositis: a case-control study. Ann. Rheum. Dis. 70, 766–771 (2011).
Rider, L. G. et al. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine 92, 223–243 (2013).
Article CAS PubMed PubMed Central Google Scholar
Schwartz, T., Sanner, H., Gjesdal, O., Flato, B. & Sjaastad, I. In juvenile dermatomyositis, cardiac systolic dysfunction is present after long-term follow-up and is predicted by sustained early skin activity. Ann. Rheum. Dis. 73, 1805–1810 (2014).
Schwartz, T. et al. In active juvenile dermatomyositis, elevated eotaxin and MCP-1 and cholesterol levels in the upper normal range are associated with cardiac dysfunction. Rheumatology 53, 2214–2222 (2014).
Article CAS PubMed Google Scholar
Barth, Z. et al. In juvenile dermatomyositis, heart rate variability is reduced, and associated with both cardiac dysfunction and markers of inflammation: a cross-sectional study median 13.5 years after symptom onset. Rheumatology 55, 535–543 (2016).
Khera, R., Khare, S. & Singh, S. K. Acute presentation of juvenile dermatomyositis with subclinical cardiac involvement: a rare case. J. Clin. Diagn. Res. 10, SD01–SD03 (2016).
PubMed PubMed Central Google Scholar
Saini, I., Kalaivani, M. & Kabra, S. K. Calcinosis in juvenile dermatomyositis: frequency, risk factors and outcome. Rheumatol. Int. 36, 961–965 (2016).
Article CAS PubMed Google Scholar
Berntsen, K. S. et al. Submaximal exercise capacity in juvenile dermatomyositis after longterm disease: the contribution of muscle, lung, and heart involvement. J. Rheumatol. 44, 827–834 (2017).
Cantez, S., Gross, G. J., MacLusky, I. & Feldman, B. M. Cardiac findings in children with juvenile Dermatomyositis at disease presentation. Pediatr. Rheumatol. Online J. 15, 54 (2017).
Article PubMed PubMed Central Google Scholar
Silverberg, J. I., Kwa, L., Kwa, M. C., Laumann, A. E. & Ardalan, K. Cardiovascular and cerebrovascular comorbidities of juvenile dermatomyositis in US children: an analysis of the National Inpatient Sample. Rheumatology 57, 694–702 (2018).
Barth, Z. et al. Association between nailfold capillary density and pulmonary and cardiac involvement in medium to longstanding juvenile dermatomyositis. Arthritis Care Res. 71, 492–497 (2019).
Ghosh, R. et al. Juvenile dermatomyositis presenting as complete heart block in a 10-year-old girl. Paediatr. Int. Child Health 40, 251–254 (2020).
Diniz, M. F. R. et al. Echocardiographic study of juvenile dermatomyositis patients: new in sights from speckle-tracking-derived strain. Clin. Rheumatol. 40, 1497–1505 (2021).
Stewart, J. A., Price, T., Moser, S., Mullikin, D. & Bryan, A. Progressive, refractory macrophage activation syndrome as the initial presentation of anti-MDA5 antibody positive juvenile dermatomyositis: a case report and literature review. Pediatr. Rheumatol. Online J. 20, 16 (2022).
Article PubMed PubMed Central Google Scholar
Witczak, B. N. et al. Body composition in long-standing juvenile dermatomyositis: associations with disease activity, muscle strength and cardiometabolic measures. Rheumatology 61, 2959–2968 (2022).
Article CAS PubMed Google Scholar
Witczak, B. N. et al. Associations between cardiac and pulmonary involvement in patients with juvenile dermatomyositis-a cross-sectional study. Rheumatol. Int. 42, 1213–1220 (2022).
Article CAS PubMed PubMed Central Google Scholar
Marstein, H. S. et al. Adipose tissue distribution is associated wit
留言 (0)